Analyst consensus rating
Greenwich LifeSciences Analyst Rating: none
GLSI is rated none by 2 analysts with a $57.00 target. As of 2026-09-02.
Direct answer
Greenwich LifeSciences's consensus rating is none.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $57.00.
Forecast evidence checked September 2, 2026.
Get free Greenwich LifeSciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $15.01
- Average price target
- $57.00
- High price target
- $69.00
- Low price target
- $45.00
- Low target gap
- +199.8%
- Target upside
- +279.7%
- High target gap
- +359.7%
- Target range width
- 159.9%
- Consensus rating
- none
- Analysts
- 2
- Evidence date
- September 2, 2026
- Valid through
- September 9, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Greenwich LifeSciences?
Greenwich LifeSciences has a verified none consensus. The same dataset has an average price target of $57.00.
How far are Greenwich LifeSciences's low and high targets from the recorded price?
The low target implies +199.8%, while the high target implies +359.7%.
How many analysts are included in Greenwich LifeSciences's consensus?
The verified consensus includes 2 analysts.
How is Greenwich LifeSciences's target upside or downside calculated?
The average target of $57.00 is divided by the recorded price of $15.01, then one is subtracted to produce +279.7%. This does not guarantee a future return.
When was Greenwich LifeSciences's analyst forecast verified?
The data was verified on 2026-09-02. The dataset is valid through 2026-09-09.